An MMP-9 mutant without gelatinolytic activity as a novel TIMP-1-antagonist.

FASEB J

Medizinische Klinik III, Institut für Biochemie, 52057 Aachen, Germany.

Published: September 2000

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.99-0947fjeDOI Listing

Publication Analysis

Top Keywords

mmp-9 mutant
4
mutant gelatinolytic
4
gelatinolytic activity
4
activity novel
4
novel timp-1-antagonist
4
mmp-9
1
gelatinolytic
1
activity
1
novel
1
timp-1-antagonist
1

Similar Publications

Article Synopsis
  • - The antioxidant protein sulfiredoxin-1 (SRX) is linked to tumor progression in colorectal cancer (CRC) and its degradation mechanism by Keap1, a protein that promotes its breakdown, was studied.
  • - Keap1 bound to SRX enhances its degradation via ubiquitination, and its absence leads to increased SRX levels, which accelerates CRC metastasis through the AP-1/MMP9 signaling pathway.
  • - Analysis suggests that reduced Keap1 and elevated SRX are associated with worse outcomes in CRC, highlighting the potential of targeting the Keap1-SRX axis for therapeutic strategies.
View Article and Find Full Text PDF

Background: A key factor in the propagation of α-synuclein pathology is the compromised protein quality control system. Variations in membrane association and astrocytic uptake between different α-synuclein forms suggest differences in exocytosis or membrane cleavage, potentially impacting the secretome's influence on dopaminergic neurons. We aimed to understand differences in protein degradation mechanisms of astrocytes for both wild-type (WT) and mutant forms of α-synuclein, specifically during periods of reduced degradation efficiency.

View Article and Find Full Text PDF

Withaferin-A induced vimentin S56 phosphorylation dissociates NEDD9 signaling loop to regress progressive metastatic melanoma into lung adenocarcinoma.

Chem Biol Interact

January 2025

Molecular Biomedicine Laboratory, Postgraduate Department of Studies and Research in Biotechnology, Sahyadri Science College, Kuvempu University, Shivamogga, 577203, Karnataka, India. Electronic address:

Article Synopsis
  • Metastasis is a complicated disease that relies on specific protein interactions, such as Vimentin and NEDD9, which are crucial for cancer progression and treatment resistance.
  • Withaferin A (WFA) is a natural compound thought to target Vimentin, potentially offering a way to inhibit metastasis, although its complete mechanism is still not clear.
  • Research has utilized various techniques, including gene expression analysis and protein interaction assays, to demonstrate that targeting the Vimentin-NEDD9 interaction with WFA can reduce melanoma spread to the lungs, highlighting its potential as a therapeutic approach.
View Article and Find Full Text PDF

Given the crucial role of specific matrix metalloproteinases (MMPs) in the extracellular matrix, an imbalance in the regulation of activation of matrix metalloproteinase-9 (MMP-9) zymogen and inhibition of the enzyme can result in various diseases, such as cancer, neurodegenerative, and gynecological diseases. Thus, developing novel therapeutics that target MMP-9 with single-chain antibody fragments (scFvs) is a promising approach. We used fluorescent-activated cell sorting (FACS) to screen a synthetic scFv antibody library displayed on yeast for enhanced binding to MMP-9.

View Article and Find Full Text PDF

To investigate the effect of phosphorylated HSP27 on the proliferation and metastasis of nasopharyngeal carcinoma and its molecular mechanism. ①Western blot assay was used to detect the expression levels of HSP27 and p-HSP27 in CNE1 and CNE2 cells of nasopharyngeal carcinoma. Inhibited the phosphorylation of HSP27, Transwell assay detected the metastasis ability of nasopharyngeal carcinoma cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!